• 0413 - 235 5879
  • drboomi@genomediscovery.org
  • No.101, 12th Cross, Rainbow Nagar, Puducherry-605 001

Combinatorial therapy for Acute Myeloid Leukemia:  A pharmaceutical mixture encompassing Metformin and Navitoclax/ABT-263 (MAN) decreases the expression of BCLAF1,  promotes differentiation of acute myeloid leukaemia cells, restores treatment responsiveness, increases therapeutic index of anticancer drugs, and promotes regression of AML via up-regulation of its target gene, 10/February/2019, 11.27 pm

Scroll Down

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION

Combinatorial therapy for Acute Myeloid Leukemia:  A pharmaceutical mixture encompassing Metformin and Navitoclax/ABT-263 (MAN) decreases the expression of BCLAF1,  promotes differentiation of acute myeloid leukaemia cells, restores treatment responsiveness, increases therapeutic index of anticancer drugs, and promotes regression of AML via up-regulation of its target gene, 10/February/2019, 11.27 pm

Spread the love
        


Spread the love
        

ABOUT OUR VISITORS

“Website without visitors is like a ship lost in the horizon.”

Page Visits --- 0
Today --- 0
Total ------ 0

"Help us make a difference by supporting our mission with your generous donation."

FOR DONATION
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!